Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 08, 2026 08:01 ET | Source: Ascendis Pharma

New Data from Week 52 of the Ongoing COACH Trial Showed that TransCon® hGH Accelerated TransCon® CNP’s Benefits Beyond Linear Growth in Children with Achondroplasia

- Unprecedented improvements in arm span observed with TransCon CNP and TransCon hGH combination therapy, a measure highly meaningful to the achondroplasia community - Enhanced improvements in spinal...
April 08, 2026 08:01 ET | Source: EXL

EXL Schedules First Quarter 2026 Financial Results Conference Call

NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- ExlService Holdings, Inc. [NASDAQ: EXLS], a global data and AI company, will release financial results for the first quarter ended March 31, 2026,...
April 08, 2026 08:00 ET | Source: Rezolve AI PLC

Rezolve Ai Goes Directly to Commerce.com Shareholders with Proposal to Create a $700+ Million Global Agentic Commerce Powerhouse

Offers 1 Rezolve Share for 2 Commerce.com Shares After Board Refuses to EngageBypasses Commerce.com Board to Stop "Wealth Destruction"Issues Fiduciary Warning as Commerce.com Faces "Terminal...
April 08, 2026 08:00 ET | Source: Kiniksa Pharmaceuticals International, Plc

Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis

– Educational campaign to raise awareness of recurrent pericarditis and to empower patients to discuss ARCALYST with their healthcare provider – – Media accompanying this announcement is available by...
April 08, 2026 08:00 ET | Source: OPKO Health, Inc.

OPKO Health’s ModeX Therapeutics Initiates Clinical Trial of MDX2301 for the Prevention of COVID-19

WESTON, Mass., April 08, 2026 (GLOBE NEWSWIRE) -- ModeX Therapeutics Inc., an OPKO Health company (NASDAQ: OPK), today announced that the first participants have been dosed in a Phase 1 clinical...
April 08, 2026 08:00 ET | Source: Pacira BioSciences

Pacira BioSciences to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference

BRISBANE, Calif., April 08, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the...
April 08, 2026 08:00 ET | Source: Xos, Inc.

Xos Steps Into the Defense Arena with Its Mobile Charging Solutions at TEVCON 2026

Xos makes its defense debut at TEVCON 2026, showcasing mobile charging solutions and joining military commanders on the Operational Energy panel.
April 08, 2026 08:00 ET | Source: Absci Corporation

Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference

VANCOUVER, Wash. and NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with...
April 08, 2026 08:00 ET | Source: Sunrun Inc.

Sunrun Announces Date for First Quarter 2026 Earnings Report

SAN FRANCISCO, April 08, 2026 (GLOBE NEWSWIRE) -- Sunrun (Nasdaq: RUN) today announced that it will issue its first quarter 2026 earnings report after the market closes on Wednesday, May 6, 2026. A...
April 08, 2026 08:00 ET | Source: Cue Biopharma, Inc.

Cue Biopharma to Receive $7.5 Million Preclinical Milestone Payment from Boehringer Ingelheim Collaboration and License Agreement

Preclinical milestone for selection and approval of first compound for lead optimization has been achievedFurther development validates the potential intended mechanistic effect of CUE-501 for T...